ImmuPharma plc (LON:IMM – Get Free Report) was up 8.4% during mid-day trading on Thursday . The stock traded as high as GBX 5.05 and last traded at GBX 5.04. Approximately 3,112,903 shares changed hands during mid-day trading, a decline of 12% from the average daily volume of 3,528,083 shares. The stock had previously closed at GBX 4.65.
ImmuPharma Trading Up 8.4%
The company has a market cap of £31.45 million, a P/E ratio of -5.66 and a beta of 3.02. The firm’s 50 day moving average price is GBX 6.38 and its 200-day moving average price is GBX 7.84.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Read More
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
